TEGRETOL Side Effects

7022131-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Rash
on Sep 15, 2010 Female patient from JAPAN , 19 years of age, was diagnosed with schizophrenia and was treated with Tegretol (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal, rash (What is rash?). Tegretol dosage: 3 Df Daily. During the same period patient was treated with VEGETAMIN (1 Df Daily) (View Vegetamin Review and Vegetamin Label ), RISPERDAL (3 Df, Unk) (View Risperdal Review and Risperdal Label ), LINTON (6 Df, Unk) (View Linton Review and Linton Label ), SEROQUEL (3 Df, Unk) (View Seroquel Review and Seroquel Label ), WINTERMIN (6 Df, Unk) (View Wintermin Review and Wintermin Label ), SEPAZON (3 Df, Unk) (View Sepazon Review and Sepazon Label ), CONTOMIN (Unk) (View Contomin Review and Contomin Label ). Patient was hospitalized.

7020210-7 | Asthenia, Decreased Appetite, Dizziness, Dysgeusia, Fatigue, Hyponatraemia, Hypophagia, Nausea, Partial Seizures
Patient was taking Tegretol (View Usage). Patient had the following side effects: asthenia, decreased appetite, dizziness (What is dizziness?), dysgeusia, fatigue, hyponatraemia, hypophagia, nausea (What is nausea?), partial seizures on Sep 16, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 226.4 lb, was diagnosed with convulsion, non-small cell lung cancer and. Tegretol dosage: Unk. During the same period patient was treated with PACLITAXEL (Unk) (View Paclitaxel Review and Paclitaxel Label ), CARBOPLATIN (Unk) (View Carboplatin Review and Carboplatin Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), DETROL (View Detrol Review and Detrol Label ), GLUCOSAMINE W/CHONDROITIN (View Glucosamine W/chondroitin Review and Glucosamine W/chondroitin Label ), FELDENE (View Feldene Review and Feldene Label ), DYAZIDE (View Dyazide Review and Dyazide Label ). Patient was hospitalized.

7020199-0 | Body Temperature Increased, C-reactive Protein Increased, Facial Pain, Hypophagia, Insomnia, Phlebitis, Platelet Count Decreased, Rash, Speech Disorder
Adverse event was reported on Sep 15, 2010 by a Male patient taking Tegretol (View Usage) (Dosage: 200 Mg Per Day) was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and. Location: JAPAN , 69 years of age, After Tegretol was administered, patient had the following side effects: body temperature increased, c-reactive protein increased, facial pain, hypophagia, insomnia, phlebitis, platelet count decreased, rash (What is rash?), speech disorder. Patient was hospitalized.

7014723-1 | Dizziness, Epilepsy, Fall, Nausea
on Sep 16, 2010 Female patient from JAPAN , 29 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Tegretol (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), epilepsy (What is epilepsy?), fall (What is fall?), nausea (What is nausea?). Tegretol dosage: 1600 Mg Daily.


7013983-0 | Convulsion
on Sep 15, 2010 Male patient from UNITED KINGDOM , 40 years of age, was diagnosed with convulsion and was treated with Tegretol (View Usage). Patient had the following side effects: convulsion. Tegretol dosage: 400 Mg, Bid.

7012358-8 | Abortion Induced
Patient was taking Tegretol (View Usage). After Tegretol was administered, patient had the following side effects: abortion induced on Sep 13, 2010 from FRANCE Additional patient health information: Female patient , 33 years of age, was diagnosed with epilepsy (What is epilepsy?) and. Tegretol dosage: 1200 Mg Daily. During the same period patient was treated with LAMISIL (200 Mg, Bid) (View Lamisil Review and Lamisil Label ). Patient was hospitalized.

7009896-0 | Asthenia, Dyskinesia, Dyspepsia, Hypotension, Leukopenia, Pyelonephritis, Urinary Tract Infection
Adverse event was reported on Sep 13, 2010 by a Female patient taking Tegretol (View Usage) (Dosage: 3.5 Df, Qd) was diagnosed with glioma and. Location: FRANCE , 46 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, dyskinesia, dyspepsia, hypotension, leukopenia, pyelonephritis, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with TEMODAL (Unk) (View Temodal Review and Temodal Label ). Patient was hospitalized.

7005253-1 | Caesarean Section, Convulsion, Loss Of Consciousness, Normal Newborn
on Sep 10, 2010 Female patient from JAPAN , 29 years of age, was diagnosed with epilepsy (What is epilepsy?), folate deficiency and was treated with Tegretol (View Usage). Patient had the following side effects: caesarean section, convulsion, loss of consciousness, normal newborn. Tegretol dosage: 400 Mg, Qd. During the same period patient was treated with LAMICTAL (100 Mg, Tid) (View Lamictal Review and Lamictal Label ), FOLIAMIN (5mg, Daily) (View Foliamin Review and Foliamin Label ).

7000905-1 | Dizziness, Malaise, Somnolence
on Sep 10, 2010 Female patient from FRANCE , 80 years of age, was treated with Tegretol (View Usage). After Tegretol was administered, patient had the following side effects: dizziness (What is dizziness?), malaise, somnolence. Tegretol dosage: 400 Mg, Qd. During the same period patient was treated with TOPIRAMATE (150 Mg, Qd) (View Topiramate Review and Topiramate Label ), AMLODIPINE (5 Mg, Qd) (View Amlodipine Review and Amlodipine Label ), TAREG (40 Mg, Unk) (View Tareg Review and Tareg Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ), STAGID (Unk) (View Stagid Review and Stagid Label ), FLECAINIDE ACETATE (Unk) (View Flecainide Acetate Review and Flecainide Acetate Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ), LODOZ (Unk) (View Lodoz Review and Lodoz Label ).

7000894-X | Convulsion
Patient was taking Tegretol (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion on Sep 09, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 40 years of age, . Tegretol dosage: 400 Mg, Bid.

6993596-7 | Coarctation Of The Aorta, Dilatation Ventricular, Endocardial Disease, Heart Disease Congenital, Myocardial Infarction
Adverse event was reported on Sep 13, 2010 by a Female patient taking Tegretol (View Usage) (Dosage: 1200 Mg Daily) . Location: FRANCE , weighting 2.19 lb, Patient had the following side effects: coarctation of the aorta, dilatation ventricular, endocardial disease, heart disease congenital, myocardial infarction. During the same period patient was treated with LAMISIL (200 Mg, Bid) (View Lamisil Review and Lamisil Label ).

6992455-3 | Dehydration, Delirium, Diarrhoea, Vomiting
on Sep 06, 2010 Female patient from MEXICO , weighting 136.7 lb, was diagnosed with epilepsy (What is epilepsy?), dementia alzheimer's type and was treated with Tegretol (View Usage). After Tegretol was administered, patient had the following side effects: dehydration, delirium, diarrhoea, vomiting. Tegretol dosage: 0.25 Df Per Day. During the same period patient was treated with EXELON (1 Patch (10 Cm2 5cm2) Per Day) (View Exelon Review and Exelon Label ). Patient was hospitalized.

6991676-3 | Blood Antidiuretic Hormone Increased, Blood Osmolarity Decreased, Deep Vein Thrombosis, Fatigue, Hyponatraemia, Inappropriate Antidiuretic Hormone Secretion, Liver Disorder, Urine Sodium Increased
on Sep 03, 2010 Male patient from JAPAN , 31 years of age, was diagnosed with temporal lobe epilepsy, deep vein thrombosis (What is deep vein thrombosis?), hepatic function abnormal and was treated with Tegretol (View Usage). Patient experienced the following unwanted or unexpected effects: blood antidiuretic hormone increased, blood osmolarity decreased, deep vein thrombosis (What is deep vein thrombosis?), fatigue, hyponatraemia, inappropriate antidiuretic hormone secretion, liver disorder, urine sodium increased. Tegretol dosage: 400 Mg Daily. During the same period patient was treated with INTERFERON ALFA 2B (100 Mcg Weekly) (View Interferon Alfa-2b Review and Interferon Alfa-2b Label ), WARFARIN POTASSIUM (1.5 Mg Daily) (View Warfarin Potassium Review and Warfarin Potassium Label ), BUCOLOME (300 Mg Daily) (View Bucolome Review and Bucolome Label ), RIBAVIRIN (800 Mg Daily) (View Ribavirin Review and Ribavirin Label ), DEMETHYLCHLORTETRACYCLINE (900 Mg Daily) (View Demethylchlortetracycline Review and Demethylchlortetracycline Label ), LITHIUM CARBONATE (400 Mg Daily) (View Lithium Carbonate Review and Lithium Carbonate Label ).

6985048-5 | Clumsiness, Dizziness
Patient was taking Tegretol (View Usage). Patient had the following side effects: clumsiness, dizziness (What is dizziness?) on Sep 03, 2010 from ARGENTINA Additional patient health information: Female patient , child 12 years of age, . Tegretol dosage: 200 Mg, Qd. During the same period patient was treated with TRILEPTAL (Unk) (View Trileptal Review and Trileptal Label ).

6981498-1 | Convulsion, Somnolence
Adverse event was reported on Sep 03, 2010 by a Female patient taking Tegretol (View Usage) (Dosage: 200 Mg In The Morning And 400 Mg In Night) . Location: BRAZIL , 33 years of age, After Tegretol was administered, patient had the following side effects: convulsion, somnolence.

6980517-6 | Dizziness, Malaise, Somnolence
on Sep 01, 2010 Female patient from FRANCE , 80 years of age, was treated with Tegretol (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), malaise, somnolence. Tegretol dosage: 400 Mg, Qd. During the same period patient was treated with TOPIRAMATE (150 Mg, Unk) (View Topiramate Review and Topiramate Label ), AMLODIPINE (Unk) (View Amlodipine Review and Amlodipine Label ), TAREG (40 Mg, Unk) (View Tareg Review and Tareg Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ), STAGID (Unk) (View Stagid Review and Stagid Label ), FLECAINIDE ACETATE (Unk) (View Flecainide Acetate Review and Flecainide Acetate Label ), CRESTOR (Unk) (View Crestor Review and Crestor Label ), LODOZ (Unk) (View Lodoz Review and Lodoz Label ).

6980510-3 | Azotaemia, Blood Creatinine Increased, Decreased Appetite, Hypoglycaemia, Malaise, Nausea, Renal Impairment
on Sep 02, 2010 Male patient from JAPAN , weighting 209.4 lb, was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?), diabetes mellitus and was treated with Tegretol (View Usage). Patient had the following side effects: azotaemia, blood creatinine increased, decreased appetite, hypoglycaemia, malaise, nausea (What is nausea?), renal impairment. Tegretol dosage: 100 Mg, Bid. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BASEN (1 Tablet, Tid) (View Basen Review and Basen Label ), MEVALOTIN (View Mevalotin Review and Mevalotin Label ), ZYLORIC ^FRESENIUS^ (View Zyloric ^fresenius^ Review and Zyloric ^fresenius^ Label ), NORVASC (View Norvasc Review and Norvasc Label ), WYTENS /JPN/ (View Wytens /jpn/ Review and Wytens /jpn/ Label ), ADALAT (View Adalat Review and Adalat Label ). Patient was hospitalized.

6980487-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, C-reactive Protein Increased, Cataract Cortical, Dry Eye, Dysphagia, Dysphonia, Eosinophil Count Increased
Patient was taking Tegretol (View Usage). After Tegretol was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased, cataract cortical, dry eye, dysphagia, dysphonia, eosinophil count increased on Sep 01, 2010 from FRANCE Additional patient health information: Female patient , 71 years of age, . Tegretol dosage: Unk. During the same period patient was treated with PAROXETINE HCL (Unk) (View Paroxetine Hcl Review and Paroxetine Hcl Label ). Patient was hospitalized.

6979104-5 | Infection, Pyrexia
Adverse event was reported on Aug 31, 2010 by a Male patient taking Tegretol (View Usage) (Dosage: 100 Mg Three Times Daily And 200 Before Going To Bed) . Location: JAPAN , 64 years of age, Patient experienced the following unwanted or unexpected effects: infection (What is infection?), pyrexia.

6979099-4 | Blood Parathyroid Hormone Increased, Hypercalcaemia, Hypercalciuria, Osteopenia, Vitamin D Deficiency
on Aug 31, 2010 Female patient from FRANCE , 53 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Tegretol (View Usage). Patient had the following side effects: blood parathyroid hormone increased, hypercalcaemia, hypercalciuria, osteopenia, vitamin d deficiency. Tegretol dosage: 400 Mg, Daily. During the same period patient was treated with LUTERAN (View Luteran Review and Luteran Label ), SURGESTONE (Unk, Long Time) (View Surgestone Review and Surgestone Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ), UVEDOSE (2 Doses,) (View Uvedose Review and Uvedose Label ).

6974278-4 | Dry Mouth, Fall, Foot Fracture, Malaise, Muscular Weakness, Speech Disorder
on Jul 30, 2010 Female patient from SPAIN , 38 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Tegretol (View Usage). After Tegretol was administered, patient had the following side effects: dry mouth, fall (What is fall?), foot fracture, malaise, muscular weakness, speech disorder. Tegretol dosage: 400 Mg, Q8h. During the same period patient was treated with KEPPRA (1500 Mg Daily) (View Keppra Review and Keppra Label ).

6974277-2 | Cytolytic Hepatitis, Febrile Bone Marrow Aplasia, Renal Failure
Patient was taking Tegretol (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, febrile bone marrow aplasia, renal failure on Jul 23, 2010 from UNITED STATES Additional patient health information: Female patient , 17 years of age, was diagnosed with small for dates baby and. Tegretol dosage: 3 Tablets A Day. During the same period patient was treated with SOMATROPIN (11.9 Mg, Qd) (View Somatropin Review and Somatropin Label ), TOPIRAMATE (View Topiramate Review and Topiramate Label ). Patient was hospitalized.

6972364-6 | Surgery
Adverse event was reported on Aug 31, 2010 by a Male patient taking Tegretol (View Usage) (Dosage: Unk) was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and. Location: JAPAN , 53 years of age, Patient had the following side effects: surgery (What is surgery?).

6969983-X | Asthenia
on Sep 03, 2010 Male patient from JAPAN , 30 years of age, was treated with Tegretol (View Usage). After Tegretol was administered, patient had the following side effects: asthenia. Tegretol dosage: . During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ), METAMFETAMINE HYDROCHLORIDE (View Metamfetamine Hydrochloride Review and Metamfetamine Hydrochloride Label ), LEVOMEPROMAZINE MALEATE (View Levomepromazine Maleate Review and Levomepromazine Maleate Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ).

6969975-0 | Chills, Cytomegalovirus Enterocolitis, Dermatitis Exfoliative, Diarrhoea, Epstein-barr Virus Antibody Positive, Erythema, Gastrointestinal Erosion, Gastrointestinal Haemorrhage
on Sep 03, 2010 Male patient from JAPAN , 61 years of age, weighting 143.3 lb, was diagnosed with hypoaesthesia and was treated with Tegretol (View Usage). Patient experienced the following unwanted or unexpected effects: chills, cytomegalovirus enterocolitis, dermatitis exfoliative, diarrhoea, epstein-barr virus antibody positive, erythema, gastrointestinal erosion, gastrointestinal haemorrhage. Tegretol dosage: Unk. Patient was hospitalized.

6969965-8 | Erythema Multiforme, Liver Disorder
Patient was taking Tegretol (View Usage). Patient had the following side effects: erythema multiforme, liver disorder on Aug 27, 2010 from JAPAN Additional patient health information: Female patient , 60 years of age, . Tegretol dosage: 100 Mg, Unk.

6969961-0 | Obesity
Adverse event was reported on Aug 26, 2010 by a Female patient taking Tegretol (View Usage) (Dosage: 600 Mg, Bid) . Location: UNITED KINGDOM , 36 years of age, After Tegretol was administered, patient had the following side effects: obesity (What is obesity?).

6967259-8 | Completed Suicide, Intentional Overdose
on Sep 03, 2010 Female patient from JAPAN , 30 years of age, was treated with Tegretol (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide, intentional overdose. Tegretol dosage: Unk.

6966852-6 | Blood Albumin Decreased, Cholelithiasis, Platelet Count Decreased, Pyrexia
on Aug 26, 2010 Female patient from JAPAN , 43 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Tegretol (View Usage). Patient had the following side effects: blood albumin decreased, cholelithiasis, platelet count decreased, pyrexia. Tegretol dosage: 2 Tablets Daily. During the same period patient was treated with ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ). Patient was hospitalized.

6966363-8 | Abnormal Behaviour, Alopecia, Anosmia, Aphasia, Bradyphrenia, Cerebellar Syndrome, Cogwheel Rigidity, Condition Aggravated
Patient was taking Tegretol (View Usage). After Tegretol was administered, patient had the following side effects: abnormal behaviour, alopecia, anosmia, aphasia (What is aphasia?), bradyphrenia, cerebellar syndrome, cogwheel rigidity, condition aggravated on Jul 27, 2010 from GERMANY Additional patient health information: Male patient , weighting 196.2 lb, was diagnosed with epilepsy (What is epilepsy?), parkinson's disease (What is parkinson's disease?) and. Tegretol dosage: 400 Mg, Qod. During the same period patient was treated with MADOPAR (62.5 Mg, Tid) (View Madopar Review and Madopar Label ), MOVERGAN (1df/day) (View Movergan Review and Movergan Label ), PARKOTIL (0.20mg/day) (View Parkotil Review and Parkotil Label ), TASMAR (Unk) (View Tasmar Review and Tasmar Label ), GABITRIL (60mg/day) (View Gabitril Review and Gabitril Label ). Patient was hospitalized and became disabled.

6966188-3 | Cough, Dyspnoea, Interstitial Lung Disease, Pyrexia
Adverse event was reported on Aug 30, 2010 by a Female patient taking Tegretol (View Usage) (Dosage: Unk, Unk) was diagnosed with epilepsy (What is epilepsy?) and. Location: JAPAN , 20 years of age, Patient experienced the following unwanted or unexpected effects: cough, dyspnoea, interstitial lung disease, pyrexia. During the same period patient was treated with CLOBAZAM (Unk) (View Clobazam Review and Clobazam Label ). Patient was hospitalized and became disabled.

6965214-5 | Accident, Fall, Hip Arthroplasty, Hip Fracture
on Aug 23, 2010 Male patient from MEXICO , 77 years of age, was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and was treated with Tegretol (View Usage). Patient had the following side effects: accident, fall (What is fall?), hip arthroplasty, hip fracture. Tegretol dosage: 3 Tablets Of 200 Mg Daily. Patient was hospitalized.

6960038-7 | Blood Glucose Increased, Erythema, Pruritus, Rash Papular
on Aug 18, 2010 Male patient from JAPAN , 70 years of age, was diagnosed with neuralgia, sciatica (What is sciatica?) and was treated with Tegretol (View Usage). After Tegretol was administered, patient had the following side effects: blood glucose increased, erythema, pruritus, rash papular. Tegretol dosage: 200 Mg, Daily. During the same period patient was treated with PAXIL (10 Mg, Unk) (View Paxil Review and Paxil Label ), DIAZEPAM (4 Mg Daily) (View Diazepam Review and Diazepam Label ), DUROTEP JANSSEN (2.1 Mg, Td) (View Durotep Janssen Review and Durotep Janssen Label ), LEPETAN (0.8 Mg, Pr) (View Lepetan Review and Lepetan Label ), TOPSYM (Unk) (View Topsym Review and Topsym Label ), ATARAX (Unk) (View Atarax Review and Atarax Label ), ZADITEN (Unk) (View Zaditen Review and Zaditen Label ). Patient was hospitalized.

6957457-1 | Asthenia
Patient was taking Tegretol (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia on Aug 25, 2010 from JAPAN Additional patient health information: Male patient , 30 years of age, . Tegretol dosage: . During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ), METAMFETAMINE HYDROCHLORIDE (View Metamfetamine Hydrochloride Review and Metamfetamine Hydrochloride Label ), LEVOMEPROMAZINE MALEATE (View Levomepromazine Maleate Review and Levomepromazine Maleate Label ), PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ).

6955309-4 | Chills, Cytomegalovirus Enterocolitis, Diarrhoea, Erythema, Gastrointestinal Erosion, Gastrointestinal Haemorrhage, Haematochezia
Adverse event was reported on Aug 25, 2010 by a Male patient taking Tegretol (View Usage) (Dosage: Unk) was diagnosed with hypoaesthesia and. Location: JAPAN , 61 years of age, Patient had the following side effects: chills, cytomegalovirus enterocolitis, diarrhoea, erythema, gastrointestinal erosion, gastrointestinal haemorrhage, haematochezia. Patient was hospitalized.

6946288-4 | Convulsion
on Aug 02, 2010 Male patient from UNITED KINGDOM , 19 years of age, was treated with Tegretol (View Usage). After Tegretol was administered, patient had the following side effects: convulsion. Tegretol dosage: .

6945063-4 | Convulsion, Drop Attacks, Myoclonus
on Aug 17, 2010 Male patient from JAPAN , child 11 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Tegretol (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, drop attacks, myoclonus. Tegretol dosage: . During the same period patient was treated with PHENOBARBITAL (View Phenobarbital Review and Phenobarbital Label ), POTASSIUM BROMIDE (View Potassium Bromide Review and Potassium Bromide Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), CLOBAZAM (Unk) (View Clobazam Review and Clobazam Label ), PHENYTOIN (Unk) (View Phenytoin Review and Phenytoin Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ).

6945052-X | Dizziness, Heart Rate Decreased, Sinus Bradycardia
Patient was taking Tegretol (View Usage). Patient had the following side effects: dizziness (What is dizziness?), heart rate decreased, sinus bradycardia on Aug 17, 2010 from JAPAN Additional patient health information: Female patient , 83 years of age, was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and. Tegretol dosage: 300 Mg, Unk. Patient was hospitalized.

6945006-3 | Caesarean Section, Normal Newborn
Adverse event was reported on Aug 14, 2010 by a Female patient taking Tegretol (View Usage) (Dosage: Two 0.5 Df, Unk) . Location: MEXICO , 34 years of age, After Tegretol was administered, patient had the following side effects: caesarean section, normal newborn. During the same period patient was treated with ATEMPERATOR LP (3 Df, Unk) (View Atemperator Lp Review and Atemperator Lp Label ), PHENYTOIN (1.5 Df, Unk) (View Phenytoin Review and Phenytoin Label ), VAIIUM (0.5 Df, Unk) (View Vaiium Review and Vaiium Label ).

6942018-0 | Deep Vein Thrombosis, Immobile, Pulmonary Embolism
on Aug 23, 2010 Male patient from UNITED KINGDOM , 41 years of age, was diagnosed with neuralgia and was treated with Tegretol (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), immobile, pulmonary embolism (What is pulmonary embolism?). Tegretol dosage: 300 Mg, Qd. During the same period patient was treated with BACLOFEN (30 Mg, Unk) (View Baclofen Review and Baclofen Label ), DIAZEPAM (6 Mg, Unk) (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

6940288-6 | Agranulocytosis, Anaemia, Febrile Neutropenia, Haemoglobin Decreased, Hemianopia Homonymous, Lactic Acidosis, Pancytopenia, Platelet Count Decreased, Pyrexia
on Aug 20, 2010 Female patient from JAPAN , weighting 90.39 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Tegretol (View Usage). Patient had the following side effects: agranulocytosis, anaemia, febrile neutropenia, haemoglobin decreased, hemianopia homonymous, lactic acidosis, pancytopenia, platelet count decreased, pyrexia. Tegretol dosage: 400 Mg, Bid. During the same period patient was treated with PHENYTOIN SODIUM (3 G, Daily) (View Phenytoin Sodium Review and Phenytoin Sodium Label ), GASTER (20 Mg, Daily) (View Gaster Review and Gaster Label ), RADICUT (60 Mg, Daily) (View Radicut Review and Radicut Label ), LENDORMIN D (0.25 Mg, Unk) (View Lendormin D Review and Lendormin D Label ), ALINAMIN F (75 Mg, Unk) (View Alinamin F Review and Alinamin F Label ). Patient was hospitalized.

6938731-1 | Completed Suicide, Intentional Overdose
Patient was taking Tegretol (View Usage). After Tegretol was administered, patient had the following side effects: completed suicide, intentional overdose on Aug 20, 2010 from JAPAN Additional patient health information: Female patient , 30 years of age, . Tegretol dosage: Unk.

6938726-8 | Accidental Overdose, Coma
Adverse event was reported on Aug 20, 2010 by a Male patient taking Tegretol (View Usage) (Dosage: Unk) . Location: BRAZIL , child 6 years of age, Patient experienced the following unwanted or unexpected effects: accidental overdose, coma.

6938137-5 | Intentional Overdose, Loss Of Consciousness, Suicidal Ideation
on Aug 10, 2010 Female patient from JAPAN , 46 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Tegretol (View Usage). Patient had the following side effects: intentional overdose, loss of consciousness, suicidal ideation. Tegretol dosage: Unk. Patient was hospitalized.

6935835-4 | Blood Pressure Decreased, Blood Urea Increased, Convulsion, Cytomegalovirus Colitis, Dehydration, Eosinophil Count Increased
on Aug 19, 2010 Male patient from JAPAN , weighting 132.3 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Tegretol (View Usage). After Tegretol was administered, patient had the following side effects: blood pressure decreased, blood urea increased, convulsion, cytomegalovirus colitis, dehydration, eosinophil count increased. Tegretol dosage: 2 Df, Qd. During the same period patient was treated with PHENOBARBITAL TAB (3 Df, Qd) (View Phenobarbital Tab Review and Phenobarbital Tab Label ), LAMICTAL (1 Df, Qd) (View Lamictal Review and Lamictal Label ), PHENYTOIN SODIUM (300 Mg) (View Phenytoin Sodium Review and Phenytoin Sodium Label ), DEPAKENE (1200 Mg) (View Depakene Review and Depakene Label ).

6935216-3 | Abscess, Fungaemia, Granulocyte Count Decreased, Interstitial Lung Disease, Oxygen Saturation Decreased, Pneumocystis Jiroveci Pneumonia, Pyrexia, Respiratory Rate Decreased
Patient was taking Tegretol (View Usage). Patient experienced the following unwanted or unexpected effects: abscess (What is abscess?), fungaemia, granulocyte count decreased, interstitial lung disease, oxygen saturation decreased, pneumocystis jiroveci pneumonia, pyrexia, respiratory rate decreased on Aug 18, 2010 from JAPAN Additional patient health information: Male patient , weighting 136.7 lb, was diagnosed with convulsion, osteoporosis (What is osteoporosis?) and. Tegretol dosage: 200 Mg, Qd. During the same period patient was treated with GABAPENTIN (2400 Mg, Unk) (View Gabapentin Review and Gabapentin Label ), BONALON (35 Mg, Unk) (View Bonalon Review and Bonalon Label ), LAMICTAL (200 Mg, Unk) (View Lamictal Review and Lamictal Label ).

6935037-1 | Dyspnoea, Erythema, Oedema Genital, Oedema Mouth
Adverse event was reported on Aug 10, 2010 by a Female patient taking Tegretol (View Usage) (Dosage: 200 Mg, Daily) was diagnosed with epilepsy (What is epilepsy?), complex partial seizures and. Location: JAPAN , 78 years of age, Patient had the following side effects: dyspnoea, erythema, oedema genital, oedema mouth. During the same period patient was treated with CELECOXIB (200 Mg, Unk) (View Celecoxib Review and Celecoxib Label ), FAMOTIDINE (20 Mg, Unk) (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

6934889-9 | Blood Creatine Phosphokinase Increased
on Aug 06, 2010 Male patient from JAPAN , 17 years of age, was diagnosed with trigeminal neuralgia (What is trigeminal neuralgia?) and was treated with Tegretol (View Usage). After Tegretol was administered, patient had the following side effects: blood creatine phosphokinase increased. Tegretol dosage: 200 Mg Daily.

6929792-4 | Convulsion, Incorrect Dose Administered, Product Quality Issue
on Aug 18, 2010 Female patient from UNITED STATES , 40 years of age, weighting 135.0 lb, was diagnosed with convulsion and was treated with Tegretol (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, incorrect dose administered, product quality issue. Tegretol dosage: 400 Mg 2x Tegratol Xr 2x Every Day.

6924796-X | Liver Disorder
Patient was taking Tegretol (View Usage). Patient had the following side effects: liver disorder on Aug 05, 2010 from JAPAN Additional patient health information: Female patient , 74 years of age, was diagnosed with neuralgia and. Tegretol dosage: Unk. Patient was hospitalized.